Welcome to the Utah Chapter of the American College of Cardiology
|
Ed Miner, MD, FACC Utah, Chapter President ACC Governor, Utah |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit:
ACC Rockies Chapter Meeting 2025
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Change in Renal Function Associated With Difference in 1-Year Survival Post Mitral TEER | NCDR StudyIn patients who underwent mitral transcatheter edge-to-edge repair (TEER), a greater than 10% change in estimated glomerular filtration rate (eGFR) was associated with differences in survival at one year, according to a study using data from the STS/ACC TVT Registry published in Structural Heart.
- HF Hospitalization Risk in T2D Lower With GLP-1RAs Than DPP-4 Inhibitors, Similar With SGLT-2 InhibitorsIn patients with type 2 diabetes (T2D), the risk of hospitalization for heart failure (HHF) was significantly lower with GLP-1RAs than DPP-4 inhibitors while it was similar compared with SGLT-2 inhibitors, according to results from real-world emulation trials published Feb. 24 in Circulation.
- Reported Shared Decision-Making and Decision Aid Use in Percutaneous LAAO | NCDR StudyAmong patients undergoing percutaneous left atrial appendage occlusion (LAAO), shared decision-making and decision aid reporting was high but varied by institution, and Medicare patients were not more likely to have reported shared decision-making with decision aids...
- Is Occupational Physical Work Exposure a Risk Factor For ATTRwt-CM?In a registry-based study, an association was found between transthyretin wild-type amyloid cardiomyopathy (ATTRwt-CM) and occupational upper-body mechanical stress, along with a greater burden of orthopedic and cardiovascular comorbidities including increased cardiovascular mortality among patients with ATTRwt-CM. The hypothesis-generating findings were published Feb. 24 in JACC: Advances.
- Nonobstructive HCM Treatment: Differential Effect of Bisoprolol vs. VerapamilBisoprolol but not verapamil reduced peak oxygen consumption (pVO2) in patients with nonobstructive hypertrophic cardiomyopathy (HCM), according to research published March 3 in JACC.